tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MDGL Stock Latest News

Madrigal Pharmaceuticals: Positive CHMP Opinion and Phase 3 Success Drive Buy Rating
RatingsMadrigal Pharmaceuticals: Positive CHMP Opinion and Phase 3 Success Drive Buy Rating
3d ago
MDGL
Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Madrigal Pharmaceuticals Holds 2025 Annual Stockholders Meeting
7d ago
8K
MDGL
Positive CHMP Opinion Boosts Madrigal Pharmaceuticals’ Prospects for Rezdiffra in EU Market
PremiumRatings
Positive CHMP Opinion Boosts Madrigal Pharmaceuticals’ Prospects for Rezdiffra in EU Market
7d ago
MDGL
Madrigal Pharmaceuticals receives positive CHMP opinion for resmetirom
PremiumThe Fly
Madrigal Pharmaceuticals receives positive CHMP opinion for resmetirom
7d ago
MDGL
Short Report: Bears bite into Krispy Kreme after another weak earnings report
PremiumThe Fly
Short Report: Bears bite into Krispy Kreme after another weak earnings report
1M ago
RKT
DNUT
Paulson buys Honeywell, boosts Madrigal in Q1
PremiumThe FlyPaulson buys Honeywell, boosts Madrigal in Q1
1M ago
AEM
BHC
Promising Phase III Trial Results Support Buy Rating for Madrigal Pharmaceuticals
Premium
Ratings
Promising Phase III Trial Results Support Buy Rating for Madrigal Pharmaceuticals
1M ago
MDGL
Uncertainties and Data Gaps Lead to Sell Rating for Madrigal Pharmaceuticals’ Rezdiffra
Premium
Ratings
Uncertainties and Data Gaps Lead to Sell Rating for Madrigal Pharmaceuticals’ Rezdiffra
1M ago
MDGL
Madrigal announces two-year results from Phase 3 MAESTRO-NAFLD-1 trial
PremiumThe Fly
Madrigal announces two-year results from Phase 3 MAESTRO-NAFLD-1 trial
2M ago
MDGL
Short Report: Bears sell into sharp rally in Hims & Hers
PremiumThe Fly
Short Report: Bears sell into sharp rally in Hims & Hers
2M ago
SVV
ASTS
Madrigal Pharmaceuticals: Strong Market Performance and Growth Potential with Rezdiffra Leading the NASH Market
PremiumRatings
Madrigal Pharmaceuticals: Strong Market Performance and Growth Potential with Rezdiffra Leading the NASH Market
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $458 from $441 at UBS
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $458 from $441 at UBS
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $460 from $422 at B. Riley
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $460 from $422 at B. Riley
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $420 from $394 at Canaccord
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $420 from $394 at Canaccord
2M ago
MDGL
Madrigal Pharmaceuticals Reports Strong Q1 2025 Results
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Q1 2025 Results
2M ago
MDGL
Madrigal’s Earnings Call: Rezdiffra’s Success and Future Plans
PremiumCompany Announcements
Madrigal’s Earnings Call: Rezdiffra’s Success and Future Plans
2M ago
MDGL
Madrigal Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatings
Madrigal Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
2M ago
MDGL
Madrigal Pharmaceuticals reports Q1 EPS ($3.32), consensus ($3.79)
PremiumThe Fly
Madrigal Pharmaceuticals reports Q1 EPS ($3.32), consensus ($3.79)
2M ago
MDGL
Madrigal Pharmaceuticals announces six presentations at EASL Congress
PremiumThe Fly
Madrigal Pharmaceuticals announces six presentations at EASL Congress
2M ago
MDGL
MDGL Earnings this Week: How Will it Perform?
PremiumPre-EarningsMDGL Earnings this Week: How Will it Perform?
2M ago
MDGL
Madrigal Pharmaceuticals’ Rezdiffra: A Promising First-Mover in MASH Treatment with Strong Growth Potential
Premium
Ratings
Madrigal Pharmaceuticals’ Rezdiffra: A Promising First-Mover in MASH Treatment with Strong Growth Potential
2M ago
MDGL
Madrigal Pharmaceuticals Announces Leadership Transition
Premium
Company Announcements
Madrigal Pharmaceuticals Announces Leadership Transition
2M ago
8K
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >